The Big Realignment: Consolidation, Distribution, and What May Happen to Everyone Below the Deal in Possible Spirits M&As
In our first live session, I sat down with Filiberto Amati. Founder of Amati and Associates and Head of Partnerships at MAFFEO DRINKS. Former executive at Campari and Di Saronno. He has been inside the machine that decides which brands survive a portfolio review, which brands get rationalized, and which brands get divested because they no longer fit the strategic narrative being told to investors. He has sat on both sides of the table.
The episode was triggered by two concurrent M&A scenarios. A potential "merger of equals" between Pernod Ricard and Brown-Forman. And a reported $15 billion cash offer from Sazerac for Brown-Forman. Neither confirmed. Both are already reshaping how the industry reads the board.
The full conversation is available below. You can also listen to the extended version on MAFFEO Confidential, the private podcast for paying members.
What follows is the strategic translation. The patterns that matter.
The Patterns That Get Missed
Two deals. One conversation. And most of the industry is reading both the same way: as a portfolio story.
Which brands overlap? Which categories get concentrated? Which gins are redundant? Which whiskey portfolios create antitrust exposure?
That is the supplier lens. It is not the commercial lens.
The two deals are not the same problem
A Pernod Ricard and Brown-Forman combination produces geographic complementarity: Pernod needs the US, Brown-Forman needs global distribution reach. A Sazerac and Brown-Forman combination concentrates rather than complements, with both companies heavily weighted toward American whiskey and a likely antitrust review timeline of two or more years.
